As editor of The Sunday Times for fourteen years, Sir Harold Evans proved to be the right man in the right place at the right time. In an investigative climate all too rare by today's standards, Evans had the freedom and resources to allow teams of journalists to work on long-term projects, including the exposure of Kim Philby as a Soviet spy. As Evans himself details in this stylish documentary, his longest and most hard fought campaign was for the victims of Thalidomide. Originally developed by the Germans in World War II to counter effect sarin gas, post-war the drug was blithely prescribed by British doctors as an antidote to morning sickness, leading to tens of thousands of children born with serious defects. The Sunday Times' fight to win compensation for their struggling families would take more than a decade, as Evans tenaciously pursued the drug companies through the English courts and beyond.
Fearing the actions of a god-like Super Hero left unchecked, Gotham City’s own formidable, forceful vigilante takes on Metropolis’s most revered, modern-day savior, while the world wrestles with what sort of hero it really needs.
One year after outwitting the FBI and winning the public’s adulation with their mind-bending spectacles, the Four Horsemen resurface in Now You See Me: The Second Act only to find themselves face to face with a new enemy who enlists them to pull off their most dangerous heist yet.
Set in the Aokigahara Forest, a real-life place in Japan where people go to end their lives. Against this backdrop, a young American woman comes in search of her twin sister, who has mysteriously disappeared.
The epic story of the first contact, encounter, approach, betrayal and, eventually, life-transcending friendship, between Karamakate, an Amazonian shaman, last survivor of his people, and two scientists that, over the course of 40 years, travel through the Amazon in search of a sacred plant that can heal them.
Have you watched Attacking the Devil: Harold Evans and the Last Nazi War Crime yet? What did you think about it?